Wed, 09th Sep 2020 00:47
BRASILIA, Sept 8 (Reuters) - Brazil health regulator Anvisa
said on Tuesday that AstraZeneca PLC had announced the
suspension of global trials for a coronavirus vaccine, which
included a human trial being done in Brazil.
AstraZeneca had directly informed Anvisa about the
suspension, the regulator said, adding that it is waiting for
further details on the reason trials were stopped.
(Reporting by Ricardo Brito; writing by Jake Spring; Editing by
Sandra Maler)
(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
Astrazeneca (AZN)